GLP-1 · Advanced protocols
Microdosing GLP-1: what it is, who it fits, and what to expect
Microdosing GLP-1s — semaglutide or tirzepatide at fractions of the FDA-approved dose — has become one of the most common protocols in longevity clinics in 2026. It targets metabolic health rather than dramatic weight loss, and avoids most of the GI side effects. Here's what it does and does not do.
Who microdosing fits
- Metabolic tune-up (insulin resistance, prediabetic A1c)
- 10-15 pounds to lose, not 40+
- Maintenance after reaching goal weight on standard dose
- GLP-1-curious patients who want to avoid full appetite suppression
- Longevity-focused adults optimizing for insulin sensitivity
What it does not do
Microdosing does not produce dramatic scale changes and is not appropriate for patients with BMI ≥30 whose insurance would cover full-dose Wegovy or Zepbound.
How kindr protocols it
Baseline labs (A1c, fasting insulin, lipids), start at 0.1 mg semaglutide weekly, hold at the dose that produces desired appetite modulation without GI symptoms. Reassess every 3 months. See semaglutide guide and tirzepatide vs semaglutide.
Frequently asked questions
What is a microdose of semaglutide?
Typically 0.1-0.25 mg weekly, one-tenth to one-fifth of the FDA-approved weight-loss dose. For tirzepatide, microdosing is usually 0.5-1.5 mg weekly.
Does microdosing GLP-1 work for weight loss?
Modestly. Expect 3-7% weight loss versus 12-18% at standard dose. Best suited for people with 10-15 pounds to lose or those focused on metabolic markers over scale change.
What are the benefits of microdosing?
Fewer GI side effects, better appetite awareness (not full suppression), improved insulin sensitivity, and less muscle loss when combined with protein and training. Popular for maintenance after standard-dose weight loss.
Is microdosing GLP-1 FDA-approved?
No. Standard doses are FDA-approved. Microdosing is off-label prescribing that requires clinician judgment. Compounded formulations make it practical because standard pens do not deliver such small doses easily.
How much does microdosing cost?
Roughly $150-300/month for compounded semaglutide microdoses, less than half of standard-dose prescriptions.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Medically reviewed by Kindr Health Clinical Team · Last reviewed 2026-06-19. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.